Health and Healthcare
5864 Articles
Oppenheimer maintained its Outperform rating for Alexion Pharmaceuticals with a price target that implies upside of more than 40%.
One positive from the hammering the pharmaceutical stocks have taken is the Merrill Lynch analysts say investors have been given…
Arrowhead Research shares soared in early trading indications Thursday in anticipation of its analyst day.
Conatus Pharmaceuticals has announced that its exploratory Phase 2 portal hypertension clinical trial of emricasan met its primary endpoints.
Canaccord Genuity reiterated a Buy rating on Intuitive Surgical with a price target that implies upside of 25% from current…
Intra-Cellular Therapies is gearing up for its secondary offering, and in preparation it just set the price.
Heron Therapeutics Inc. (NASDAQ: HRTX) is bucking the trend of a biotechs and pharmas selling off in the wake of…
ThinkstockSignal Genetics Inc. (NASDAQ: SGNL) soared right out of the gate Wednesday morning on word of a new agreement. Basically,…
Orexigen Therapeutics has announced receipt of the first of three potential $15 million anniversary milestone payments from Takeda Pharmaceuticals.
The recent outcry on social media, focusing on drug pricing, is likely to draw attention to the role of pharmacy…
Ampio Pharmaceuticals made waves in the market on Tuesday morning and it looked like a day trader’s dream.
Neogen reported disappointing fiscal first-quarter financial results before the markets opened on Monday morning.
On Monday, a simple tweet from presidential candidate Hillary Clinton managed to wreck the biotech sector.
Edge Therapeutics is offering more than 5 million shares in its initial public offering in an expected price range of…
NovoCure has made an updated filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Our top personal finance-related articles today. Your wallet will thank you later.